| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, Duvelisib, lipid kinase inhibitor targeting PIK3CD (Novartis, 50905713) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/50905713 |
| Similar Terms | |
| Downloads & Tools |
5 genes differentially expressed following the CB-99-NG16_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| CA3 | carbonic anhydrase III | 0.500847 |
| RSL24D1 | ribosomal L24 domain containing 1 | 0.239803 |
| RPS11 | ribosomal protein S11 | 0.229188 |
| RPL19 | ribosomal protein L19 | 0.219126 |
| Symbol | Name | Standardized Value |
|---|---|---|
| SAFB | scaffold attachment factor B | -0.219126 |